Testimonials

shake hand

"...David is a hard working and intelligent asset for any team. At Wintherix he was directly responsible for writing several composition of matter patents that constitute the majority of the company's intellectual property. He worked in close conjunction with our chemists to not only draft patents on existing compounds but to also give insight on the generation of new compounds in a novel patent space. For anyone looking for guidance in Medicinal Chemistry or needing to draft patents for less than the big law firms charge David is your man..." February 2, 2010.

John Hood, Ph.D. , Chief Scientific Officer , Wintherix, LLC.

"...David did a superb job in completing a patent application under tight time constraints. He is highly skilled as a patent writer, knowing exactly what to include and able to work closely with our scientists to assemble a high-quality document with remarkable efficiency. The cost was probably half that of using our patent law firm. David is energetic, enthusiastic, and highly responsive. I look forward to future opportunities to engage his services ..." April 27, 2010 .Scott Hecker, Ph.D., Vice President of Chemistry at Mpex Pharmaceuticals, Inc.

 

 

A Few Words About Us

David M. Wallace, Ph.D. President and Founder

Dr. Wallace is president and founder of Wallace Scientific Consulting, a provider of medicinal chemistry consulting and intellectual property services to industry and academia.

 

Dr. Wallace received a doctorate degree in organic chemistry from the University of California, Davis. He has more than 18 years of experience in the pharmaceutical and biotech industry leading medicinal chemistry teams. Projects have targeted various enzymes and receptors (G-protein coupled receptors, nuclear hormone receptors, kinases, bacterial efflux pumps) covering a variety of diseases such as oncology, cardiovascular, inflammatory, metabolic and antimicrobial.

 

Dr. Wallace is a registered patent agent (#64957) and has more than five years of experience drafting provisional and nonprovisional patent applications. He is an inventor on seven issued patents and more than a dozen provisional and published nonprovisional applications.

 

 

Curriculum Vitae

 

RECENT PROJECTS

Scientific Consulting Services

 

Provided technical guidance on an oncology project focused on wnt-related signaling pathways.

Designed and set-up 2 antimicrobial research programs. Provided synthetic strategies and targets for both projects.

Co-managed teams of chemists in Poland and China to synthesize aminoglycoside antibiotics and bacterial efflux-pump inhibitors.

Designed efflux-pump inhibitor libraries and managed the Chinese CRO responsible for the synthesis.

Set-up and managed off-site chemistry operations for a small start-up company.

Assisted client with the preparation of research proposals for Small Business Innovation Research (SBIR) grants.

Worked with the client to provide an in-depth assessment of different product opportunities including market potential, time to market, technical feasibility and intellectual property leading to the selection of an optimal set of 5 products for the company's pipeline.

Set-up 5 person chemistry synthesis laboratory, established chemistry department's initial budget, reviewed resumes and interviewed candidates.

Provided Due Diligence reports on potential academia and industrial project in-licenses. This included

Evaluation of available scientific data.

Evaluation of the competitive advantage, competition, market and potential revenue.

Evaluation of the projects of IP position.

 

IP Consulting Services

Managed client company's pharmaceutical patent portfolio.

Developed ideas and strategies for subject matter of provisional and non-provisional patent applications prior to filing.

Drafted provisional applications

Converted provisional applications into non-provisional utility patents.

Performed Prior art and Patentability searches.

Performed Freedom to Operate searches.

Assisted with preparation of IP Due Diligence report as part of informational package for potential corporate investor.

 

 

 

more